The news landed like a thunderclap in a San Francisco conference room on June 30, 2026. Anthropic, the artificial intelligence company behind the cutting-edge Claude model, announced it will launch its own preclinical drug-discovery programs targeting neglected diseases, including rare conditions, while simultaneously unveiling Claude Science, an AI workbench built for […]
The post Anthropic is launching its own drug discovery programs for rare diseases using Claude superintelligence appeared first on Activist Post.
